Sectra

Sectra (Booth 9124) is featuring the capabilities and functionality of its Sectra MicroDose Mammography, L30 full-field digital mammography (FFDM) platform, and is premiering an integrated mammography screening solution.

The firm also is showcasing the new generation of its photon-counting FFDM system, Sectra MicroDose Mammography, L30, currently the only commercially available photon-counting mammography system on the market, according to Sectra. It is available for sale outside of the U.S. Photon-counting is a technology for better images, lower dose and fundamental advantages in several advanced applications, such as contrast mammography, dual-energy and tomosynthesis.

The company also is demonstrating an integrated solution for mammography screening, including Sectra Screening RIS, Sectra MicroDose Mammography and Sectra Breast Imaging PACS, all designed to efficiently streamline mammography workflow.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.